Ghost Tree Capital as of March 31, 2018
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 52 positions in its portfolio as reported in the March 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Incyte Corporation (INCY) | 16.9 | $83M | 8.3k | 10000.00 | |
| SPDR S&P Biotech (XBI) | 7.1 | $35M | 8.8k | 4000.00 | |
| Immunomedics | 5.5 | $27M | 1.9M | 14.61 | |
| Endocyte | 4.0 | $20M | 2.2M | 9.09 | |
| Sarepta Therapeutics (SRPT) | 3.5 | $17M | 235k | 74.09 | |
| Iovance Biotherapeutics (IOVA) | 3.4 | $17M | 1.0M | 16.90 | |
| Avexis | 3.4 | $17M | 135k | 123.58 | |
| Biohaven Pharmaceutical Holding | 3.3 | $16M | 625k | 25.76 | |
| Rocket Pharmaceuticals (RCKT) | 3.2 | $16M | 850k | 18.75 | |
| Mylan Nv | 2.9 | $14M | 350k | 41.17 | |
| Argenx Se (ARGX) | 2.4 | $12M | 150k | 80.44 | |
| Catalyst Biosciences | 2.4 | $12M | 450k | 25.80 | |
| Amicus Therapeutics (FOLD) | 2.3 | $11M | 750k | 15.04 | |
| Blueprint Medicines (BPMC) | 2.2 | $11M | 120k | 91.70 | |
| Ascendis Pharma A S (ASND) | 1.9 | $9.2M | 140k | 65.40 | |
| Momenta Pharmaceuticals | 1.8 | $9.1M | 500k | 18.15 | |
| Dicerna Pharmaceuticals | 1.8 | $9.1M | 950k | 9.56 | |
| ACADIA Pharmaceuticals (ACAD) | 1.8 | $9.0M | 400k | 22.47 | |
| Mirati Therapeutics | 1.6 | $8.1M | 263k | 30.70 | |
| Concert Pharmaceuticals I equity | 1.6 | $8.0M | 350k | 22.90 | |
| Adamas Pharmaceuticals | 1.6 | $7.8M | 325k | 23.90 | |
| Allergan | 1.5 | $7.6M | 45k | 168.29 | |
| Assembly Biosciences | 1.5 | $7.4M | 150k | 49.14 | |
| Retrophin | 1.4 | $7.0M | 314k | 22.36 | |
| Kadmon Hldgs | 1.4 | $6.8M | 1.6M | 4.25 | |
| Flamel Technologies Sa (AVDL) | 1.2 | $6.2M | 850k | 7.29 | |
| Arrowhead Pharmaceuticals (ARWR) | 1.2 | $5.8M | 800k | 7.21 | |
| Viewray (VRAYQ) | 1.2 | $5.8M | 900k | 6.43 | |
| Aquinox Pharmaceuticals | 1.1 | $5.6M | 400k | 14.08 | |
| G1 Therapeutics (GTHX) | 1.1 | $5.6M | 150k | 37.05 | |
| Ptc Therapeutics I (PTCT) | 1.1 | $5.4M | 200k | 27.06 | |
| Obseva Sa | 1.1 | $5.4M | 400k | 13.50 | |
| Neos Therapeutics | 1.0 | $5.0M | 600k | 8.30 | |
| Aduro Biotech | 0.9 | $4.7M | 500k | 9.30 | |
| CurrencyShares Swiss Franc Trust | 0.9 | $4.5M | 46k | 98.41 | |
| Mersana Therapeutics (MRSN) | 0.9 | $4.4M | 278k | 15.77 | |
| Tg Therapeutics (TGTX) | 0.9 | $4.3M | 300k | 14.20 | |
| Glycomimetics (GLYC) | 0.8 | $4.1M | 250k | 16.23 | |
| Lannett Company | 0.8 | $4.0M | 250k | 16.05 | |
| Clovis Oncology | 0.8 | $4.0M | 75k | 52.80 | |
| Infinity Pharmaceuticals (INFIQ) | 0.7 | $3.7M | 1.8M | 2.10 | |
| Tesaro | 0.7 | $3.5M | 62k | 57.14 | |
| Solid Biosciences | 0.6 | $2.9M | 385k | 7.50 | |
| Jounce Therapeutics | 0.6 | $2.8M | 125k | 22.35 | |
| Dbv Technologies S A (DBVT) | 0.5 | $2.3M | 100k | 23.07 | |
| Sage Therapeutics (SAGE) | 0.4 | $1.8M | 11k | 161.08 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.3 | $1.3M | 550k | 2.39 | |
| Karyopharm Therapeutics (KPTI) | 0.2 | $1.0M | 77k | 13.41 | |
| Nabriva Therapeutics | 0.2 | $1.0M | 200k | 5.03 | |
| Anaptysbio Inc Common (ANAB) | 0.2 | $937k | 9.0k | 104.11 | |
| Motus Gi Hldgs Incorporated | 0.1 | $448k | 100k | 4.48 | |
| ImmunoGen | 0.1 | $225k | 7.5k | 30.00 |
